Haemophilia trials in Singapore

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A First-in Human Study of ARD001 in Healthy Volunteers and People With Hemophilia A

  Where

  Singapore

  Age

  21 years to 45 years

  People

  20

  Run by

  Arditus Pte Ltd

  See details and how to joinNCT07787091
• Phase 3Taking people
  Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

  Where

  Singapore

  Age

  18 years and over

  People

  35 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT06003387 · EU 2023-509590-23-00